CLINICAL TRIAL: A MULTICENTER PHASE 1-2A STUDY OF DIMEBON IN SUBJECTS WITH HUNTI

临床试验：DIMEBON 在 HUNTI 受试者中的多中心 1-2A 期研究

• 批准号: 7724946
• 负责人: JODY COREY-BLOOM
• 金额: $ 4.44万
• 依托单位: UNIVERSITY OF CALIFORNIA, SAN DIEGO
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-12-01 至 2008-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7724946
• 关键词: Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Huntington Disease; Institution; Phase; Research; Research Personnel; Resources; Safety; Source; United States National Institutes of Health; dimebolin; dosage

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Determine the safety and tolerability of orally administered Dimebon during dosage escalation in subjects with mild to moderate Huntington's disease.

该子项目是利用该技术的众多研究子项目之一 资源由 NIH/NCRR 资助的中心拨款提供。子项目和 研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金， 因此可以在其他 CRISP 条目中表示。列出的机构是 对于中心来说，它不一定是研究者的机构。 确定患有轻度至中度亨廷顿舞蹈病的受试者在剂量递增过程中口服 Dimebon 的安全性和耐受性。